Amarin Corporation plc (NASDAQ: AMRN) ("Amarin"), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today highlighted the important scientific and educational ...
In Part 1 and Part 2, we covered how to calculate your cardiovascular risk in the Cardiovascular-Kidney-Metabolic (CKM) framework and what markers and risk factors to measure. In Part 3 (#70) of this ...
Combined assessment of TyG index values and hsCRP levels may improve early identification of individuals at increased risk for hyperuricemia.
USA: A recent case report published in Clinical Case Reports by Sushrut Ingawale from Quinnipiac University Frank H. Netter ...
Monthly olezarsen reduced triglycerides and apolipoprotein B in patients with hypertriglyceridemia but may have no impact on ...
Considering turmeric’s anti-inflammatory properties, it’s not surprising that researchers have investigated its use for ...
New research reveals that obesity affects men and women in surprisingly different ways. Men are more likely to develop harmful abdominal fat and signs of liver stress, while women show higher ...
Modern medicine is improving in precision, identifying exactly who needs treatment and who doesn’t. In heart disease ...
MHRA approves olezarsen (Tryngolza) for the treatment of familial chylomicronemia syndrome The Medicines and Healthcare products Regulatory Agency ...
And it’s true that increasing intake of omega-3-rich foods (like fatty fish) improves cholesterol, triglycerides, blood ...
What nuts are good for cholesterol? Nuts proven to reduce cholesterol levels include almonds, walnuts, cashews, pistachios, ...
Over the past five years, CRISPR Therapeutics (CRSP) has significantly underperformed the broader market. There are multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results